Latest News & Features
Refine Search
Africa
Global intellectual property strategy will be the chief area of focus for IP counsel in the life sciences arena in 2017. 26 January 2017
Americas
US-based drugs company Aralez Pharmaceuticals has filed a patent infringement complaint against Teva centring on the drug Yosprala, a delayed-release aspirin. 25 January 2017
Americas
The US Court of Appeals for the Federal Circuit has vacated a district court’s grant of summary judgment of non-infringement and remanded a case involving China-based Zhejiang Medicine, Japanese company Keneka and ZMC-USA. 25 January 2017
Americas
Endo Pharmaceuticals yesterday settled charges brought by the Federal Trade Commission by abandoning anti-competitive pay-for-delay agreements. 24 January 2017
Africa
The World Trade Organization has amended its intellectual property rules to make it easier for poor countries to access affordable medicines. 24 January 2017
Big Pharma
Gilead’s marketing authorisation application for sofosbuvir 400mg, velpatasvir 100mg and voxilaprevir 100mg—treatments for chronic hepatitis C virus—is under assessment by the European Medicines Agency. 23 January 2017
Americas
Merck has agreed a settlement and licensing agreement with Bristol-Myers Squibb (BMS) and Ono Pharmaceutical under which it will pay the companies $625 million. 23 January 2017
Americas
Novartis, Mitsubishi Tanabe Pharma and Mitsui Sugar have filed a complaint against Aurobindo Pharma for patent infringement. 20 January 2017
Americas
The US Supreme Court has declined to hear the Johnson & Johnson v Rembrandt Vision Technologies patent case centring on contact lens technology. 20 January 2017
Americas
Biogen and Forward Pharma, a Denmark-based company, have entered into a settlement and licensing agreement under which Biogen will pay Forward Pharma $1.25 billion. 19 January 2017